felin
infecti
peritonti
fip
elus
frustrat
problem
veterinari
practition
cat
breeder
mani
year
last
sever
year
report
begun
elucid
aspect
molecular
biolog
causal
viru
fipv
paper
complement
rapidli
grow
base
knowledg
concern
molecular
organ
replic
coronavirus
gener
fascin
immunopathogenesi
fipv
infect
viru
interact
macrophag
also
subject
sever
recent
paper
clear
fipv
may
interest
scientist
veterinari
virologist
sinc
pathogenesi
may
provid
use
model
system
virus
whose
infect
enhanc
presenc
virusspecif
antibodi
advanc
recent
releas
first
commerciallyavail
fipv
vaccin
appropri
review
known
organ
replic
coronavirus
pathogenesi
fipv
infect
list
abbrevi
adeantibodydepend
enhanc
bcvbovin
coronaviru
c
complement
cadecomplementmedi
antibodydepend
enhanc
ccvcanin
coronaviru
cnscentral
nervou
system
crcomplement
receptor
cvlpcoronaviruslik
particl
dsdoublestrand
dthdelayedtyp
hypersensit
eavequin
arter
viru
fcr
fc
receptor
fecv
felin
enter
coronaviru
felv
felin
leukemia
viru
fip
felin
infecti
periton
fipv
felin
infecti
periton
viru
human
coronaviru
coronaviru
hehemagglutin
esteras
hevhemagglutin
encephalomyel
viru
hivhuman
immunodefici
viru
hrsvhuman
respiratori
syncyti
viru
ibv
infecti
bronchiti
viru
kb
kilobas
kda
kilodalton
ldhv
lactat
dehydrogenas
viru
membran
protein
mab
monoclon
antibodi
mhc
major
histocompat
mhvmous
hepat
viru
mrnamesseng
rna
nnucleocapsid
protein
nlink
asparaginelink
glycosyl
ns
nonstructur
protein
olink
serineor
th
reoninelink
glycosyl
orf
open
read
frame
pol
polymeras
protein
prcv
porcin
respiratori
coronaviru
rcv
rat
coronaviru
recv
rabbit
enter
coronaiviru
ri
replic
intermedi
rhuifn
recombin
human
interferon
alpha
spike
protein
sdav
sialodacryoaden
viru
siv
simian
immunodefici
viru
spf
specificpathogenfre
cultur
infecti
dose
tcvturkey
coronaviru
tgevtransmiss
gastroenter
viru
tstemperaturesensit
vnviru
neutral
ize
histori
felin
infecti
periton
first
describ
diseas
entiti
holzworth
wolf
griesem
etiolog
diseas
uncertain
viru
particl
describ
cat
fip
ward
earli
paper
ward
notabl
outlin
sever
salient
featur
regard
viral
etiolog
fip
confirm
recent
studi
includ
tropism
viru
macrophag
presenc
virion
vesicl
cysterna
golgi
bodi
lack
plasma
membran
bud
viru
presenc
clublik
project
surfac
virion
ward
colleagu
ward
ward
et
al
suggest
viru
respons
fip
might
member
coronavirida
evid
character
includ
structur
similar
mous
hepat
viru
mhv
put
fipv
diseas
similar
fip
mhvrelat
diseas
possibl
associ
coronaviru
retroviru
felin
leukemia
viru
felv
fipv
murin
leukemia
virusmhv
respect
etiolog
diseas
confirm
viral
etiolog
elucid
pathogenesi
fip
hamper
number
year
difficulti
encount
isol
fipv
clinic
case
grow
viru
vitro
first
cultiv
viru
vitro
accomplish
use
periton
exud
cell
cultur
pedersen
pedersen
confirm
subcellular
local
virion
featur
macrophag
tropism
first
describ
ward
viru
subsequ
grown
felin
small
intestin
organ
cultur
hoshino
scott
final
growth
serial
passag
continu
cell
line
felin
origin
viru
produc
fip
upon
experiment
inocul
cat
demonstr
viru
also
character
coronaviru
oreilli
et
al
coronavirida
famili
coronavirida
includ
pathogen
sever
mammalian
avian
speci
famili
defin
morpholog
group
spheric
pleomorph
larg
nm
envelop
virus
helic
nucleocapsid
core
wege
et
al
project
envelop
coronaviru
virion
fring
club
wege
et
al
petalshap
holm
spike
peplom
spike
given
rise
name
coronaviru
analog
either
corona
sun
crown
thorn
corona
spinarum
use
mediev
artwork
holm
coronavirus
histor
arrang
antigen
five
group
wege
et
al
one
group
includ
fipv
relat
felin
enter
coronaviru
fecv
canin
coronaviru
ccv
transmiss
gastroenter
viru
swine
tgev
human
coronaviru
second
group
includ
human
coronaviru
relat
isol
mhv
rat
coronaviru
rcv
sialodacryoaden
viru
sdav
bovin
coronaviru
bcv
hemagglutin
encephalomyel
viru
swine
hev
avian
coronavirus
classifi
two
separ
group
typifi
infecti
bronchiti
viru
ibv
chicken
turkey
coronaviru
tcv
also
sever
unclassifi
coronavirus
includ
enter
coronaviru
rabbit
recv
descoteaux
lussier
coronaviru
induc
myocard
experiment
inocul
rabbit
edward
et
al
coronaviru
isol
hors
mair
et
al
within
classif
framework
recent
work
suggest
barrier
antigen
group
absolut
tcv
shown
relat
antigen
ibv
well
two
mammalian
coronavirus
mhv
bcv
dea
et
al
furthermor
evolutionari
relationship
tcv
bcv
mhv
support
genet
sequenc
analysi
end
virus
verbeek
tijssen
also
evid
recent
monoclon
antibodi
mab
analysi
move
tgev
group
sanchez
et
al
beyond
chang
within
coronaviru
famili
coronavirida
seen
repres
larger
rna
viru
superfamili
torovirus
isol
hors
snijder
et
al
cattl
koopman
et
al
cat
muir
et
al
human
beard
et
al
though
morpholog
differ
torovirus
tubular
nucleocapsid
genom
organ
snijder
et
al
snijder
et
al
protein
structur
snijder
et
al
torovirus
coronavirus
similar
evid
recombin
torovirus
coronavirus
coevolut
equin
arter
viru
eav
contain
icosahedralcor
classifi
histor
togaviru
includ
coronaviru
superfamili
similar
genet
organ
anoth
tradit
member
togavirida
lactat
dehydrogenaseelev
viru
ldhv
also
similar
genet
coronavirus
kuo
et
al
coronavirus
appear
enter
cell
via
plasma
membran
fusion
without
signific
involv
phagocyt
endosom
pathway
kooi
et
al
payn
et
al
stoddart
sturman
et
al
weismil
et
al
neither
cytochalasin
b
disrupt
cellular
microfila
phagocytosi
lysosomotrop
base
elev
endosom
ph
affect
infect
macrophag
fipv
stoddart
bcv
infect
human
rectal
tumor
cell
likewis
unaffect
lysosomotrop
base
electron
microscop
analysi
demonstr
bcv
fusion
plasmalemma
intracellular
membran
payn
et
al
mhv
infect
fibroblast
also
found
larg
independ
endocytot
pathway
kooi
et
al
abil
given
coronaviru
infect
specif
host
andor
tissu
thought
depend
upon
presenc
specif
cellular
receptor
lai
receptor
mhv
recent
identifi
murin
enterocyt
hepatocyt
membran
clone
dvelsler
et
al
receptor
kilodalton
kda
glycoprotein
immunoglobulin
superfamili
amino
acid
sequenc
antigen
homolog
member
carcinoembryon
antigen
famili
protein
transfect
fibroblast
put
mhv
receptor
gene
confer
suscept
infect
wherea
mab
receptor
block
infect
dvelsler
et
al
addit
presenc
function
form
receptor
correl
tissu
mous
strain
suscept
infect
mhv
date
work
publish
concern
receptor
fipv
number
review
outlin
molecular
biolog
coronavirus
holm
lai
spaan
et
al
sturman
holm
drawn
upon
creat
model
recent
advanc
molecular
biolog
fipv
integr
replic
coronavirus
accomplish
entir
cytoplasm
infect
cell
genom
coronavirus
singlestrand
rna
posit
polar
upon
initi
infect
cell
genom
rna
function
messeng
rna
mrna
coronavirus
among
largest
rna
virus
genom
ibv
kilobas
kb
viral
replic
transcript
occur
via
format
doublestrand
ds
rna
replic
intermedi
ri
stretch
highli
conserv
nucleotid
base
end
genom
identifi
negativestrand
initi
signal
lai
tradit
thought
new
positivesens
genomiclength
rna
well
positivesens
subgenom
mrna
transcrib
genomiclength
ri
lai
et
al
howev
result
recent
studi
tgev
sethna
et
al
sethna
et
al
mhv
sawicki
sawicki
bcv
liu
et
al
demonstr
transcript
via
subgenom
ri
well
coronaviru
mrna
form
set
ie
mrna
share
sequenc
end
number
ofmrna
vari
among
differ
coronavirus
fipv
ibv
produc
mrna
tgev
produc
mrna
bcv
produc
mrna
includ
genomiclength
mrna
case
despit
variat
number
consensu
code
pattern
among
coronavirus
gene
order
polymeras
pol
polyprotein
spike
protein
membran
protein
nucleocapsid
n
protein
nonstructur
ns
protein
gene
variabl
interspers
lai
code
assign
known
size
fipv
strain
mrna
follow
mrna
kbgenom
rna
de
groot
et
al
mrna
kb
protein
de
groot
et
al
de
groot
et
al
mrna
kb
de
groot
et
al
mrna
kbm
protein
de
groot
et
al
vennema
et
al
mrna
kbn
protein
de
groot
et
al
vennema
et
al
mrna
kbopen
read
frame
orf
de
groot
et
al
fecv
strain
mrna
found
kb
shorter
correspond
fipv
mrna
suggest
delet
nucleotid
end
fecv
genom
bain
although
smallest
coronaviru
mrna
structur
polycistron
function
monocistron
sinc
uniqu
orf
mrna
translat
lai
spaan
et
al
except
includ
mrna
encod
polymeras
protein
see
mrna
mhv
mrna
tgev
spaan
et
al
mrna
oflbv
liu
et
al
mrna
fipv
de
groot
et
al
fipv
mrna
encod
polypeptid
kda
protein
kda
protein
homolog
tgev
also
encod
mrna
tgev
mrna
kda
protein
structur
similar
membran
protein
de
groot
et
al
tgev
mrna
lack
homolog
de
groot
et
al
thu
delet
end
fecv
genom
compar
fipv
genom
bain
may
interest
sinc
tgev
fecv
larg
restrict
replic
enterocyt
wherea
fipv
infect
macrophag
varieti
tissu
system
genomiclength
mrna
coronavirus
encod
rnadepend
rna
polymeras
protein
lai
research
mhv
demonstr
two
tempor
enzymat
distinct
polymeras
activ
mhv
transcript
addit
vitro
translat
genomiclength
mrna
result
detect
two
predomin
protein
product
product
shown
ntermin
portion
larger
precursor
protein
could
detect
twodimension
gel
electrophoresi
mhvinfect
cell
late
time
hour
infect
denison
perlman
clone
sequenc
vitro
translat
ibv
brieirli
et
al
brieirli
et
al
mhv
lee
et
al
pol
mrna
reveal
case
two
orf
translat
via
frameshiftingpseudoknot
produc
pol
polyprotein
nucleotid
lee
et
al
protein
denison
et
al
sequenc
analysi
mhv
pol
region
also
delin
number
put
function
domain
includ
membran
anchor
cysteinerich
proteas
domain
orfla
lee
et
al
well
polymeras
helicas
zincfing
domain
proteas
cleavag
site
b
denison
et
al
lee
et
al
similar
domain
also
identifi
ibv
gorbalenya
et
al
toroviru
eav
denboon
et
al
polymeras
despit
identif
domain
sequenc
analysi
still
unclear
exact
relationship
compon
protein
identifi
earli
late
polymeras
activ
function
defin
howev
group
temperaturesensit
ts
mutant
mhv
identifi
mutat
fell
complement
group
rel
positiveand
negativesens
rna
transcript
schaad
et
al
sequenc
analysi
mutat
may
allow
assign
distinct
polymeras
function
specif
polymeras
protein
compon
given
coronaviru
genomiclength
subgenom
mrna
contain
ident
leader
sequenc
length
vari
among
differ
coronavirus
lai
colleagu
work
mhv
pioneer
research
role
leader
rna
coronaviru
transcript
leader
segment
sever
mhv
mrna
speci
sequenc
found
ident
sequenc
also
found
end
genomiclength
rna
suggest
rna
code
mrna
leader
via
complementari
end
negativesens
strand
ri
lai
colleagu
reason
sinc
coronaviru
replic
entir
cytoplasm
process
convent
eukaryot
splice
nuclear
process
could
explain
find
also
found
sequenc
complementari
region
near
end
leader
initi
site
mrna
suggest
role
leader
transcript
initi
makino
colleagu
demonstr
mix
infect
two
differ
mhv
strain
bi
respect
leader
sequenc
could
freeli
reassort
makino
et
al
demonstr
reassort
recombin
occur
high
frequenc
makino
et
al
makino
et
al
also
appear
recombin
occur
randomli
respect
site
crossov
banner
lai
previou
report
suggest
recombin
crossov
site
cluster
near
hypervari
region
gene
banner
et
al
abil
studi
recombin
may
play
critic
role
elucid
question
coronaviru
pathogenesi
bain
recombin
alreadi
use
local
function
import
epitop
protein
mhv
makino
et
al
coronaviru
transcript
thu
propos
occur
via
discontinu
leaderprim
mechan
lai
leader
transcrib
end
ri
negativesens
strand
dissoci
templat
reassoci
templat
intergen
site
prime
downstream
transcript
site
leader
reassoci
templat
determin
homolog
bind
sequenc
near
end
leader
sequenc
consensu
sequenc
intergen
region
consensu
intergen
sequenc
identifi
preceed
orf
fipv
degroot
et
al
n
vennema
et
al
protein
end
mhv
leader
contain
repeat
ucuaa
sequenc
also
imperfectli
repeat
intergen
site
lai
number
repeat
leader
vari
among
strain
mhv
also
chang
passag
vitro
lai
makino
et
al
pentanucleotid
repeat
thought
play
import
role
bind
leader
intergen
sequenc
rna
makino
et
al
coronaviru
mrna
synthes
equal
amount
transcript
individu
rel
rate
synthesi
constant
throughout
transcript
rel
abund
mrna
speci
progress
increas
along
genom
kone
et
al
two
factor
may
respons
govern
gradient
mrna
level
rel
degre
homolog
thu
bind
effici
leader
rna
intergen
sequenc
makino
et
al
intern
initi
event
leaderprim
transcript
may
occur
slowli
enough
block
elong
pass
transcript
kone
et
al
later
theori
propos
upstream
transcript
forc
paus
new
site
initi
thu
prematur
termin
dissoci
templat
incomplet
transcript
previous
detect
makino
et
al
ultim
mechan
may
act
togeth
govern
mrna
level
addit
recognit
subgenomicmrna
replic
hoffman
et
al
sawicki
sawicki
sethna
et
al
sethna
et
al
possibl
differ
effici
subgenomicmrna
replic
may
also
affect
mrna
level
coronavirus
encod
least
three
structur
protein
formerli
formerli
n
holm
spaan
et
al
sturman
holm
protein
form
peplom
project
surfac
virion
respons
receptor
bind
induct
celltocel
fusion
fusion
viral
envelop
target
cell
membran
induct
neutral
ab
induct
cellmedi
immun
cmi
respons
addit
alter
protein
shown
affect
virul
ofmhv
dalziel
et
al
bcv
mhv
protein
also
fc
receptorlik
activ
oleszak
et
al
bind
nonspecif
ab
cell
surfaceexpos
protein
may
protect
infect
cell
virusspecif
ab
attach
antibodydepend
cellular
cytox
oleszak
et
al
coronaviru
protein
kda
glycoprotein
asparaginelink
nlink
oligosaccharid
attach
contain
ntermin
signal
sequenc
larg
domain
exterior
viru
envelop
transmembran
domain
ctermin
hydrophil
tail
interior
viru
envelop
peplom
consist
molecul
protein
arrang
coiledcoil
structur
de
groot
et
al
de
groot
et
al
sequenc
polypeptid
divid
two
region
ntermin
portion
region
transmembran
domain
studi
fipv
confirm
protein
also
nlink
glycosyl
olsen
et
al
vennema
et
al
structur
similar
gener
coronaviru
protein
de
groot
et
al
respons
mediat
celltocel
fusion
neutral
ab
induct
de
groot
et
al
substanti
interest
extent
proteolyt
cleavag
occur
among
coronavirus
result
appear
depend
upon
viru
question
well
cell
type
involv
frana
et
al
protein
ibv
bcv
appear
cleav
consist
binn
et
al
cavanaugh
et
al
cleavag
mhv
protein
vari
among
differ
mhv
strain
protein
fipv
ccv
tgev
thought
cleav
howev
trypsinsensit
cleavag
site
recent
demonstr
protein
fipv
fecv
bain
cleavag
site
occur
normal
process
viru
cell
cultur
cleavag
exogen
trypsin
increas
viru
infect
crandel
felin
kidney
cell
crfkc
cleavag
howev
increas
abil
attenu
strain
fipv
infect
felin
macrophag
bain
latent
cleavag
site
may
also
exist
tgev
protein
rasschaert
laud
degre
amino
acid
sequenc
homolog
among
protein
variou
coronavirus
differ
portion
polypeptid
comparison
fipv
mhv
ibv
reveal
homolog
littl
homolog
degroot
et
al
within
fipv
antigen
group
virus
howev
much
greater
homolog
throughout
protein
signific
degre
antigen
homolog
note
among
protein
tgev
porcin
respiratori
coronaviru
prcv
fipv
fecv
ccv
sanchez
et
al
comparison
gene
sequenc
tgev
fipv
reveal
homolog
first
amino
acid
homolog
residu
jacob
et
al
extens
effort
gone
map
domin
antigen
site
protein
oftgev
correa
et
al
delma
et
al
garwa
et
al
gebauer
et
al
laviada
et
al
posthumu
et
al
bcv
yoo
et
al
ibv
koch
et
al
kuster
et
al
mhv
makino
et
al
routledg
et
al
stuhler
et
al
takeseyoden
et
al
fipv
olsen
et
al
case
multipl
neutral
domain
delin
immunodomin
domain
gener
locat
portion
protein
neutral
domain
howev
identifi
well
koch
et
al
kuster
et
al
makino
et
al
posthumu
et
al
routledg
et
al
fipv
protein
number
epitop
defin
appear
mediat
viru
neutral
antibodydepend
enhanc
ade
fipv
infect
olsen
et
al
olsen
et
al
coronaviru
protein
cotransl
glycosyl
major
protein
incorpor
bud
virion
smaller
portion
transport
plasma
membran
sturman
holm
protein
incorpor
virion
transport
substanti
faster
recombinantexpress
protein
degroot
et
al
vennema
et
al
suggest
exist
retent
signal
cytoplasm
tail
vennema
et
al
second
studi
howev
would
appear
refut
presenc
retent
signal
sinc
cterminallytrunc
protein
express
recombin
vaccinia
viru
complet
retain
endoplasm
reticulum
er
infect
cell
pulford
britton
trimer
tgev
protein
shown
occur
primarili
stage
carbohydr
moieti
partial
trim
termin
glycosyl
occur
mainli
trimer
protein
delma
luad
addit
oligomer
appear
ratelimit
step
transport
oftgev
protein
er
golgi
bodi
delma
luad
antigen
site
tgev
protein
may
structur
depend
upon
independ
trimer
howev
major
antigen
site
protein
tgev
appear
requir
least
coreglycosyl
delma
laud
appear
case
protein
fipv
olsen
et
al
despit
high
degre
antigen
homolog
protein
fipv
tgev
jacob
et
al
membran
protein
coronavirus
smaller
surfac
glycoprotein
approxim
kda
size
oppos
substanti
extern
portion
coronaviru
protein
ntermin
portion
protein
protrud
viral
envelop
form
glycosyl
nlink
olink
presenc
absenc
signal
peptid
protein
vari
among
differ
coronavirus
protein
oftgev
pulford
britton
ibv
lai
fipv
fecv
bain
nlink
glycoprotein
wherea
glycosyl
protein
mhv
olink
lai
coronavirus
lack
ntermin
signal
sequenc
protein
one
three
alpha
helic
span
develop
viru
membran
may
function
signal
sequenc
first
membran
span
domain
may
also
respons
target
protein
golgi
macham
et
al
protein
necessari
viru
matur
insert
golgi
membran
determin
via
interact
n
protein
site
viru
assembl
bud
holm
lai
spaan
et
al
though
protein
tradit
associ
induct
protect
immun
respons
coronavirus
mab
protein
mhv
shown
protect
mice
acut
enceph
fleme
et
al
addit
recombin
vaccinia
viru
express
protein
fipv
induc
protect
challeng
virul
fipv
vaccin
cat
vennema
et
al
third
structur
protein
common
coronavirus
n
protein
n
protein
highli
basic
protein
kda
phosphoryl
serin
residu
like
mani
viral
nucleocapsid
protein
coronaviru
n
protein
encas
genom
rna
play
integr
part
format
helic
nucleocapsid
addit
n
protein
appear
critic
viral
transcript
vitro
studi
demonstr
antibodi
n
protein
inhibit
transcript
mhv
subsequ
studi
confirm
specif
interact
n
protein
mhv
leader
rna
base
end
leader
rule
direct
bind
n
protein
negativesens
rna
ri
stohlman
et
al
author
suggest
n
protein
may
integr
part
transcript
complex
possibl
function
open
secondari
structur
constraint
known
occur
region
n
bind
target
transcript
complex
protein
leader
rna
discontinu
transcript
process
serv
prevent
rnarna
base
pair
transcript
sequenc
comparison
n
gene
strain
mhv
demonstr
n
protein
contain
highli
homolog
domain
separ
variabl
spacer
region
central
domain
appear
respons
rna
bind
parker
master
level
n
protein
may
also
act
switch
transcriptionmrna
synthesi
replicationgenom
rna
synthesi
coronavirus
lai
involv
n
protein
transcript
helic
rna
virus
mean
limit
coronavirus
n
protein
function
similarli
transcript
replic
rhabdovirus
banerje
fourth
structur
protein
present
certain
strain
mhv
well
bcv
glycoprotein
approxim
function
exist
dimer
hogu
et
al
spaan
et
al
protein
bcv
shown
hemagglutin
activ
receptordestroy
enzym
acetylesteras
activ
hogu
et
al
spaan
et
al
storz
et
al
vlasak
et
al
recent
work
howev
indic
protein
bcv
actual
effici
hemagglutinin
protein
schultz
et
al
protein
identifi
fipv
complet
coronaviru
replic
cycl
requir
encapsid
viral
rna
releas
virion
infect
cell
recent
studi
mhv
demonstr
encapsid
sequenc
end
orflb
makino
et
al
van
der
et
al
locat
would
explain
fact
genomiclength
mhv
rna
packag
van
der
et
al
howev
bcv
hoffman
et
al
tgev
sethna
et
al
subgenom
rna
also
packag
suggest
encapsid
sequenc
site
may
consist
among
coronavirus
subsequ
passag
golgi
matur
virion
may
releas
postgolgi
vesicl
either
fusion
plasma
membran
cell
lysi
holm
coronavirus
produc
broad
rang
diseas
manifest
respect
host
mclntosh
wege
et
al
mani
coronavirus
induc
diseas
limit
singl
organ
system
instanc
tcv
bcv
ccv
recv
fecv
tgev
produc
primarili
enter
diseas
ibv
rcv
hcv
mainli
respiratori
tract
pathogen
respiratori
coronaviru
also
identifi
recent
swine
initi
sought
high
incid
tgev
ab
popul
pig
without
evid
tgevrel
enter
diseas
pensaert
et
al
van
nieuwstadt
pol
experiment
sever
clinic
diseas
associ
porcin
respiratori
coronaviru
prcv
infect
vari
mild
otool
et
al
fatal
van
nieuwstadt
pol
may
depend
upon
strain
dose
prcv
age
piglet
challeng
though
prcv
primarili
infect
epitheli
cell
macrophag
respiratori
tract
also
capabl
limit
replic
gastrointestin
tract
cox
et
al
cox
et
al
otool
et
al
like
fipv
fecv
tgev
prcv
similar
antigen
across
n
protein
though
mab
analysi
protein
appear
offer
method
differenti
two
virus
callebaut
et
al
callebaut
et
al
genet
comparison
prcv
tgev
reveal
delet
prcv
gene
first
ns
gene
downstream
page
et
al
rasschaert
et
al
wesley
et
al
interestingli
analysi
small
plaqu
variant
tgev
also
reveal
alter
ns
gene
downstream
wesley
et
al
variant
viru
also
exhibit
differ
cell
tropism
within
small
intestin
previous
note
fecv
genom
also
appear
delet
comparison
fipv
oppos
coronavirus
induc
diseas
primarili
singl
organ
system
diseas
manifest
mhv
fipv
infect
involv
varieti
organ
wege
et
al
mhv
infect
exact
natur
diseas
produc
hepat
neurolog
enter
depend
upon
strain
viru
rout
dose
inocul
well
host
factor
age
genet
makeup
levi
et
al
wege
et
al
pathogen
differ
strain
mice
also
correl
abil
viru
either
replic
lyse
macrophag
lymphocyt
mediat
cellinduc
express
procoagul
monokin
chung
et
al
lamontagn
et
al
lamontagn
et
al
lamontagn
jolicoeur
levi
abecassi
similar
correl
host
resist
viru
infect
vivo
intrins
resist
morahan
et
al
ofmacrophag
infect
vitro
document
sever
viru
famili
mogensen
seen
natur
fip
also
multifactori
regard
viru
strain
host
paramet
virusimmun
cell
interact
fipv
one
coronavirus
infect
cat
notabl
distinct
must
drawn
fipv
fecv
pedersen
pedersen
et
al
pedersen
et
al
stoddart
gaskel
tupper
et
al
fecv
infect
gener
inappar
induc
mild
enter
though
sever
enter
diseas
seen
young
specificpathogenfre
spf
kitten
pedersen
pedersen
et
al
b
clinic
sign
may
includ
lowgrad
fever
mucoid
diarrhea
sometim
hematochezia
occasion
vomit
anorexia
lethargi
transient
leukopenia
may
accompani
onset
diarrhea
fecv
target
epithelium
small
intestin
histolog
villou
atrophi
may
develop
promin
jejunum
ileum
sever
case
serum
antibodi
appear
day
infect
pedersen
fecv
must
also
differenti
coronaviruslik
particl
cvlp
cvlp
detect
fece
varieti
speci
anim
without
diarrhea
includ
rodent
dog
cat
pig
cow
poultri
speci
man
nonhuman
primat
hoshino
scott
cvlp
detect
fece
clinic
normal
cat
morpholog
similar
cvlp
speci
hoshino
scott
cvlp
distinguish
enter
coronavirus
base
upon
ultrastructur
characterist
surfac
project
coronaviru
peplom
typic
petalshap
short
stalk
wherea
project
surfac
cvlp
spheric
teardropshap
attach
via
long
stalk
hoshino
scott
base
upon
distinct
one
report
dea
et
al
felin
cvlp
may
describ
true
enter
coronaviru
role
cvlp
pathogen
agent
ident
virus
yet
conclus
determin
mcintosh
vital
import
realiz
multipl
strain
fipv
fecv
vari
substanti
pathogen
fiscu
et
al
fiscu
teramoto
pedersen
floyd
stoddart
stoddart
scott
among
fipv
strain
instanc
rel
avirul
intermedi
virul
extrem
virul
pedersen
floyd
felin
coronavirus
also
separ
two
group
base
upon
reactiv
proteinspecif
mab
group
virus
typifi
fipv
strain
nw
group
ii
consist
includ
fecv
fiscu
teramoto
fiscu
teramoto
hohdatsu
et
al
lb
classif
fipv
strain
ucd
l
vari
studi
type
antigen
classif
may
also
reflect
biolog
characterist
rate
intern
celltocel
spread
fiscu
teramoto
certain
strain
felin
coronavirus
eg
yayoi
strain
appar
produc
enter
diarrhea
well
fatal
fip
hayashi
et
al
exist
intermedi
strain
antigen
similar
among
fipv
fecv
isol
may
indic
felin
coronavirus
simpli
differ
biotyp
singl
prototyp
viru
scott
even
suggest
fipv
strain
directli
deriv
fecv
mutat
recombin
gastrointestin
tract
infect
cat
evermann
et
al
pedersen
et
al
final
cat
also
infect
heterolog
coronavirus
speci
cat
infect
experiment
tgev
shed
viru
fece
mount
homolog
heterolog
humor
immun
respons
reynold
garw
convers
pig
infect
oral
virul
fipv
demonstr
clinic
sign
histolog
lesion
coronavir
antigen
local
typic
tgev
infect
wood
et
al
cat
infect
ccv
remain
clinic
normal
demonstr
homolog
well
heterolog
humor
immun
respons
viru
detect
stool
barlough
et
al
infect
cat
result
homolog
antibodi
respons
littl
replic
viru
inocul
anim
barlough
et
al
given
potenti
crossspeci
infect
close
antigen
relationship
fipv
fecv
tgev
ccv
pedersen
et
al
sanchez
et
al
virus
may
hostrang
mutant
one
anoth
clinic
characterist
fip
domest
cat
well
outlin
barlough
scott
hoskin
pedersen
pedersen
floyd
scott
stoddart
gaskel
although
cat
age
may
affect
diseas
occur
often
cat
month
year
age
major
case
occur
cat
year
age
addi
jarrett
scott
suggest
incid
fip
greater
among
purebr
cat
pedersen
though
unclear
whether
reflect
actual
genet
predisposit
infect
increas
fipv
exposur
transmiss
catteri
situat
scott
although
attack
rate
fip
greater
catteri
multicat
household
still
diseas
usual
occur
sporad
pedersen
transmiss
fipv
thought
occur
via
ingest
inhal
subsequ
cattocat
contact
fipv
shed
infect
cat
fece
oronas
secret
viru
shed
document
occur
day
experiment
infect
thu
cat
probabl
shed
viru
time
clinic
ill
scott
stoddart
et
al
b
c
report
transplacent
transmiss
reproduct
tract
diseas
manifest
scott
rout
transmiss
form
diseas
yet
conclus
proven
experiment
anecdot
report
howev
indic
queen
seroposit
possibl
seroneg
may
repeatedli
give
birth
kitten
develop
fip
first
month
life
scott
surviv
fipv
environ
tradit
assum
quit
limit
given
envelop
natur
coronavirus
recent
report
howev
suggest
dri
onto
surfac
infecti
viru
may
persist
week
scott
nonetheless
fipv
readili
inactiv
commonli
use
disinfect
scott
incub
period
fip
vari
greatli
may
short
two
week
clinic
diseas
may
evid
month
year
follow
infect
scott
exist
fipv
latent
carrier
state
remain
assumpt
support
circumstanti
evid
prolong
incub
period
appar
activ
clinic
diseas
upon
subsequ
infect
felv
pedersen
corticosteroid
treatment
pedersen
floyd
addit
recent
studi
multicat
household
uk
also
support
exist
asymptomat
cartier
cat
import
fipv
transmiss
potenti
fipv
shed
subsequ
first
day
infect
addi
jarrett
two
major
form
fip
effus
wet
form
noneffus
dri
form
addit
may
combin
form
multipl
granuloma
limit
local
fluid
accumul
effus
form
diseas
fibrinrich
fluid
accumul
periton
pleural
pericardi
andor
renal
subcapsular
space
specif
sign
exhibit
cat
depend
upon
site
effus
abdomin
enlarg
seen
periton
fluid
accumul
gener
nonpain
dyspnea
may
accompani
signific
pleural
effus
sign
ofcor
pulmonal
may
accompani
pericardi
effus
renal
subcapsular
fluid
accumul
sometim
palpabl
upon
physic
examin
regardless
site
fluid
extravas
certain
gener
sign
typic
present
case
anorexia
weight
loss
listless
dehydr
fever
fever
may
fluctuat
diurnal
longer
pattern
specif
sign
may
occur
extens
inflammatori
process
peritoneum
specif
organ
eg
jaundic
hepat
involv
likewis
exocrin
endocrin
pancreat
insuffici
may
becom
evid
pancreat
involv
rare
sign
associ
noneffus
fip
unpredict
discret
natur
organ
involv
pyogranulomat
lesion
fever
howev
particularli
consist
form
fip
may
initiallyevid
clinic
sign
consequ
fip
promin
ruleout
cat
present
feverofunknownorigin
central
nervou
system
cn
ocular
involv
common
noneffus
form
fip
cn
sign
may
reflect
spinal
cord
involv
uppermotor
neuron
paresi
ataxia
cerebr
cerebellomedullari
lesion
ataxia
nystagamu
behavior
chang
seizur
sign
ocular
diseas
may
accompani
manifest
fip
may
clinic
appar
evid
fip
commonli
uveal
tract
involv
result
iriti
uveiti
chorioretin
retin
hemorrhag
detach
panophthalm
may
also
occur
cours
diseas
tend
differ
variou
form
fip
cat
effus
diseas
gener
progress
along
fulmin
cours
death
week
sever
month
young
kitten
tend
surviv
shortest
period
time
noneffus
form
diseas
may
wax
wane
period
mani
month
particularli
case
ocular
involv
understand
pathogenesi
fip
still
incomplet
evolv
clear
exposur
fipv
consist
correl
develop
clinic
diseas
pedersen
diseas
determin
may
includ
strain
fipv
involv
pedersen
floyd
dose
rout
infect
pedersen
et
al
la
nonspecif
stress
factor
age
stoddart
gaskel
immun
statusfelv
statu
pedersen
genet
makeup
cat
pedersen
support
role
genet
factor
come
possibl
increas
incid
fip
purebr
cat
natur
fip
cheetah
fipv
document
caus
clinic
diseas
varieti
exot
felid
speci
includ
cheetah
sand
cat
carac
lynx
cougar
jaguar
leopard
palla
cat
lion
barlough
scott
pedersen
cheetah
howev
appear
except
sensit
fipv
infect
fipv
infect
captiv
breed
coloni
cheetah
oregon
produc
diseas
storm
high
morbid
mortal
investig
epizoot
evermann
et
al
obrien
et
al
demonstr
cheetah
genet
homogen
major
histocompat
mhc
loci
hypothes
lack
mhc
variabl
cheetah
may
defici
abil
present
fipv
antigen
mount
protect
immun
respons
obrien
et
al
recent
character
domest
cat
mhc
winkler
et
al
allow
investig
possibl
genet
basi
increas
incid
fip
purebr
domest
cat
follow
oronas
infect
fipv
first
replic
pharyng
respiratori
hayashi
et
al
scott
intestin
epitheli
cell
pedersen
primarili
cellassoci
viremia
subsequ
occur
monocyt
predomin
cell
type
infect
weiss
scott
l
b
monocyt
like
serv
distribut
fipv
target
organ
throughout
bodi
viru
local
macrophag
reticuloendotheli
organ
perivascularli
mani
organ
weiss
scott
c
histolog
lesion
fip
character
necrot
pyogranuloma
phlebiti
thrombosi
weiss
scott
c
one
perplex
aspect
pathogenesi
fip
frequent
occurr
acceler
fulmin
diseas
upon
fipv
challeng
seroposit
compar
seroneg
cat
acceler
fip
first
document
shown
onset
clinic
diseas
among
experiment
infect
kitten
correl
appear
serum
antibodi
pedersen
boyl
confirm
result
came
demonstr
onset
viremia
clinic
sign
thrombocytopenia
lymphopenia
appear
viral
antigen
necrot
lesion
affect
tissu
occur
earlier
seroposit
kitten
seroneg
kitten
weiss
scott
l
b
weiss
scott
l
c
surviv
time
also
significantli
shorter
seroposit
kitten
pedersen
boyl
weiss
scott
lb
addit
seroneg
kitten
given
immun
serum
pedersen
boyl
weiss
scott
antifipv
igg
pedersen
boyl
challeng
develop
clinic
diseas
manner
time
cours
seroposit
kitten
jacobsegeel
colleagu
jacobsegeel
et
al
demonstr
immun
complex
complement
c
deposit
fip
host
protein
well
fipv
protein
demonstr
immun
complex
purifi
sera
ascit
fluid
cat
fip
horzinek
et
al
though
potenti
signific
autoimmun
compon
pathogenesi
fip
yet
evalu
activ
c
inflamatori
mediat
cascad
well
blood
coagul
cascad
may
initi
subclin
dissemin
intravascular
coagul
dic
demonstr
experiment
fip
weiss
et
al
inflamatori
mediat
implic
pathogenesi
fip
includ
ill
goitsuka
et
al
goitsuka
et
al
leukotrien
prostaglandin
weiss
vaughn
demonstr
immun
complex
deposit
fip
initi
seem
explain
patholog
chang
fip
phenomenon
acceler
fip
howev
new
consider
introduc
demonstr
antibodydepend
enhanc
ade
fipv
infect
macrophag
vitro
hohdatsu
et
al
olsen
et
al
olsen
et
al
stoddart
antibodydepend
enhanc
viru
infect
occur
monocyt
macrophag
effici
infect
complex
viru
plu
ab
via
receptormedi
endocytosi
viru
alon
porterfield
sinc
ade
viru
infect
vitro
first
document
hawk
demonstr
wide
rang
virus
partial
list
includ
flavivirus
west
nile
viru
murray
valley
enceph
viru
cardosa
et
al
pieri
porterfield
alphavirus
semliki
forest
viru
sindbi
viru
western
equin
enceph
viru
chana
et
al
pieri
porterfield
bunyavirus
lewi
et
al
pieri
porterfield
human
respiratori
syncyti
viru
hrsv
gimenez
et
al
krilov
et
al
influenza
viru
ochiai
et
al
ldhv
inada
mim
rabi
viru
king
et
al
murin
cytomegaloviru
reovirus
burstin
et
al
arenavirus
lewi
et
al
howev
inform
work
regard
ade
viru
infect
come
studi
dengu
viru
dv
human
immunodefici
viru
hiv
recent
fipv
see
despit
descript
ade
viru
infect
numer
question
remain
regard
actual
basi
enhanc
instanc
receptor
mediat
ade
viru
infect
tradit
process
attribut
fc
receptor
fcr
igg
fcri
fcrii
littaua
et
al
porterfield
work
hiv
simian
immunodefici
viru
siv
howev
demonstr
enhanc
viru
infect
via
fcr
alon
homsi
et
al
takeda
et
al
via
c
receptor
cr
presenc
c
ab
cade
montefiori
et
al
b
robinson
et
al
robinson
et
al
presenc
c
alon
robinson
et
al
via
fcr
connor
et
al
takeda
et
al
presenc
solubl
allan
et
al
werner
et
al
synthet
peptid
hiv
derossi
et
al
absenc
serum
c
cr
implic
ade
flavivirus
well
cardosa
et
al
date
report
ade
fipv
infect
hohdatsu
et
al
olsen
et
al
stoddart
report
fcrmediat
enhanc
absenc
c
given
involv
c
activ
pathogenesi
fip
jacobsegeel
et
al
jacobsegeel
et
al
potenti
cade
fipv
need
address
well
second
question
specif
viral
compon
mediat
ade
infect
viru
mab
use
delin
viral
protein
specif
epitop
involv
ade
ofdv
hiv
robinson
et
al
b
fipv
hohdatsu
et
al
olsen
et
al
fipv
studi
olsen
et
al
indic
enhanc
strictli
mediat
epitop
protein
third
paper
found
proteinspecif
mab
could
also
mediat
ade
fipv
infect
hohdatsu
et
al
associ
fact
individu
epitop
capabl
mediat
viru
neutral
vn
ade
viru
infect
clearli
shown
dv
halstead
et
al
moren
halstead
hiv
robinson
et
al
well
fipv
hohdatsu
et
al
olsen
et
al
subclass
given
ab
determin
whether
abl
mediat
neutral
ade
viru
infect
result
fipv
suggest
mab
mediat
process
mab
mediat
vn
report
ade
hiv
infect
found
depend
upon
ig
subclass
sinc
report
cade
result
nt
refut
conclus
fipv
report
work
ade
fipv
infect
demonstr
bellshap
distribut
enhanc
rel
ab
concentr
maxim
enhanc
occur
subneutr
concentr
ab
olsen
et
al
similar
result
obtain
dv
moren
halstead
mechanist
bind
enhanc
ab
particular
epitop
viru
induc
increas
viru
infect
suggest
enhanc
ab
increas
bind
viru
cell
surfac
therebi
potenti
product
interact
viru
normal
cell
surfac
receptor
connor
et
al
madi
et
al
porterfield
support
bispecif
ab
dv
hiv
varieti
cell
surfac
molecul
addit
fcr
found
enhanc
viru
infect
connor
et
al
madi
et
al
howev
result
situ
hybrid
analysi
ade
fipv
infect
found
differ
initi
uptak
viru
macrophag
infect
presenc
absenc
enhanc
ab
viru
system
also
suggest
enhanc
ab
may
facilit
uncoat
jolli
porterfield
robinson
et
al
ultim
question
bear
ade
viru
infect
describ
vitro
upon
pathogenesi
diseas
vivo
develop
viru
vaccin
question
fuel
ongo
debat
among
research
ofdv
halstead
moren
halstead
rosen
hiv
bolognesi
homsi
et
al
robinson
et
al
substanti
bodi
epidemiolog
inform
suggest
ade
dv
infect
macrophag
underli
develop
sever
form
dengu
call
dengu
hemorrhag
fever
dengu
shock
syndrom
experiment
data
howev
larg
restrict
measur
viremia
level
clinic
patholog
paramet
nonhuman
primat
halstead
halstead
et
al
attempt
made
correl
presenc
enhanc
ab
serum
hivinfect
patient
progress
aquir
immunodefici
syndrom
howev
vitro
enhanc
level
demonstr
fairli
low
number
patient
limit
homsi
et
al
hrsv
ab
may
function
enhanc
infect
also
enhanc
leukotrien
product
infect
cell
ananaba
anderson
recent
result
fipv
candid
vaccin
test
seem
provid
strongest
support
date
direct
relationship
enhanc
infect
vitro
enhanc
diseas
vivo
inocul
cat
recombin
vaccinia
viru
express
protein
fipv
sensit
cat
led
acceler
diseas
fipv
challeng
vennema
et
al
inocul
recombin
vaccinia
virus
express
n
protein
fipv
predispos
cat
acceler
diseas
vennema
et
al
result
vivo
also
support
vitrodefin
local
enhanc
epitop
protein
fipv
olsen
et
al
addit
recent
experi
among
group
cat
use
studi
efficaci
candid
fip
vaccin
demonstr
statist
signific
associ
certain
challeng
condit
abil
cat
serum
mediat
enhanc
fipv
infect
vitro
develop
acceler
fip
vivo
difficult
make
definit
diagnosi
fip
biopsi
subsequ
histopatholog
examin
absolut
conclus
method
antemortem
diagnosi
barlough
scott
short
varieti
factor
must
taken
togeth
support
diagnosi
fip
barlough
scott
pedersen
scott
stoddart
gaskel
spark
et
al
clinicopatholog
patient
may
demonstr
follow
depend
upon
particular
organ
system
affect
elev
serum
liver
enzym
bilirubin
level
elev
serum
urea
nitrogen
creatinin
level
elev
fibrinogen
level
decreas
pack
cell
volum
neutrophilia
lymphopenia
proteinuria
analysi
blood
protein
level
may
help
albumin
level
may
normal
decreas
globulin
level
often
increas
serum
protein
electrophoresi
commonli
demonstr
polyclon
gammopathi
case
effus
fip
analysi
fluid
obtain
abdominoor
thoracocentesi
may
help
fluid
gener
yellow
though
may
variou
degre
bloodting
viscou
visibl
strand
fibrin
fluid
analysi
reveal
high
specif
graviti
elev
protein
level
variabl
number
inflammatori
cell
fluid
may
clot
upon
stand
cerebrospin
fluid
may
reveal
elev
protein
level
increas
cellular
fip
affect
cn
abil
util
serolog
test
diagnosi
fipv
infect
clinic
fip
limit
earli
serolog
studi
reveal
local
gener
cat
popul
cat
fip
problem
catteri
seroposit
cat
develop
clinic
diseas
pedersen
result
suggest
mild
primari
form
diseas
pedersen
sever
classic
fip
uncommon
secondari
sequela
pedersen
subsequ
discoveri
antigenicallyrel
fecv
suggest
vast
major
seroposit
test
result
may
indic
exposur
fecv
rather
fipv
pedersen
point
presenc
serum
coronaviru
antibodi
cat
whether
healthi
diseas
indic
prior
exposur
coronaviru
fipv
antigen
group
barlough
scott
littl
predicit
diagnost
valu
scott
addit
cat
fip
elev
coronaviru
ab
titer
recent
studi
cat
fip
coronaviru
titer
cat
test
neg
coronaviru
ab
spark
et
al
earli
attempt
serolog
discrimin
cat
infect
fipv
versu
fecv
uniformli
unsuccess
ingersol
wyli
b
howev
mab
distinguish
fipv
fecv
recent
identifi
hohdatsu
et
al
mab
may
provid
basi
competit
enzymelink
immunosorb
assay
differenti
cat
exposur
fipv
fecv
fiscu
teramato
one
final
complic
felin
coronaviru
serolog
test
cat
may
produc
ab
direct
bovin
serum
compon
possibl
result
presenc
routin
vaccin
prepar
barlough
scott
ab
produc
fals
posit
coronaviru
titer
bovin
serum
also
use
propag
target
virus
use
coronaviru
ab
test
crossreact
ab
decreas
period
month
vaccin
barlough
scott
treatment
cat
suffer
fip
larg
symptomat
eg
fluid
replac
nutrit
support
due
immunolog
natur
diseas
immunosuppress
dose
corticosteroid
mg
prednisolon
per
kg
per
day
often
prescrib
along
broad
spectrum
antibiot
barlough
scott
less
commonli
immunosuppress
drug
cyclophosphamid
melphalan
use
barlough
scott
ribavirin
human
recombin
alpha
interferon
rhulfna
felin
fibroblast
beta
ifn
shown
inhibit
fipv
replic
vitro
weiss
oostromram
weiss
toiviokinnucan
vivo
highdos
therapi
rhulfna
immunomodul
drug
deriv
propionibacterium
acn
success
suppress
clinic
sign
diseas
prolong
surviv
time
cat
unabl
significantli
protect
fatal
diseas
weiss
et
al
potenti
long
unpredict
incub
period
fip
difficulti
inher
identifi
cat
shed
viru
distinguish
fipv
fecv
serolog
respons
surviv
fipv
environ
surpris
felin
coronavirus
notori
difficult
control
multicat
environ
becom
increasingli
clear
control
contact
kitten
adult
carrier
cat
may
critic
factor
control
enzoot
fip
catteri
addi
jarret
shown
isol
kitten
queen
rest
catteri
popul
reduc
seroconvers
among
kitten
isol
kitten
queen
well
week
age
complet
elimin
seroconvers
among
kitten
addi
jarrett
jarrett
howev
role
queen
complic
special
form
immun
may
confer
infect
queen
offspr
pedersen
floyd
demonstr
kitten
born
fipvinfect
queen
could
resist
challeng
virul
fipv
suggest
natur
transmiss
fipv
queen
kitten
earli
age
may
provid
form
premunit
immun
pedersen
floyd
given
immunemedi
pathogenesi
fip
basi
protect
immun
fipv
infect
clearli
humor
immun
protect
pedersen
form
immun
would
seem
exist
howev
sinc
report
though
rare
spontan
remiss
rate
seroposit
cat
far
exce
incid
clinic
diseas
pedersen
suggest
cmi
respons
may
import
immun
pedersen
floyd
scott
weiss
cox
evalu
delayedtyp
hypersensit
dth
skin
reaction
fipv
antigen
cat
initi
found
strong
dth
respons
fipresist
cat
minim
respons
suscept
cat
weiss
cox
subsequ
work
subject
document
similar
result
lethal
challeng
fipv
cat
posit
dth
respons
fipv
antigen
increas
surviv
time
compar
dth
cat
weiss
cox
support
import
cmi
respons
fipv
resist
come
work
nude
mice
follow
intracerebr
challeng
fipv
mortal
rate
significantli
higher
homozyg
nunu
heterozyg
nu
nude
mice
takenouchi
et
al
sever
intestin
lesion
also
note
fipv
challeng
thymectom
kitten
oppos
normal
kitten
hayashi
et
al
howev
cmi
respons
may
also
contribut
granulomat
lesion
seen
noneffus
fip
cmi
respons
partial
protect
pedersen
weiss
cox
consid
lack
understand
constitut
protect
immun
fipv
infect
problem
ade
infect
diseas
develop
safe
effect
vaccin
fipv
problemat
varieti
approach
unsuccess
olsen
scott
includ
administr
inactiv
fipv
scott
avirul
fipv
fipv
subleth
dose
virul
fipv
pedersen
pedersen
black
heterolog
ccv
tgev
live
viru
vaccin
barlough
et
al
barlough
et
al
wood
pedersen
recombin
vaccinia
viru
express
fipv
protein
vennema
et
al
recent
temperaturesensit
mutant
fipv
develop
fipv
vaccin
christianson
et
al
vaccin
strain
deriv
passag
parent
fipv
cell
cultur
passag
c
follow
ultraviolet
irradi
intranas
vaccin
cat
induc
strong
mucos
iga
lymphocyt
blastogenesi
respons
gerber
gerber
et
al
vaccin
safeti
demonstr
parenter
administr
administr
corticosteroidand
felvimmunosuppress
cat
administr
cat
previous
expos
fecv
gerber
gerber
et
al
mean
vaccin
efficaci
calcul
author
publish
data
prevent
fraction
experiment
challeng
studi
conduct
manufactur
gerber
howev
independ
test
vaccin
complet
partial
refut
initi
report
gerber
efficaci
safeti
result
data
present
scott
et
al
indic
abil
vaccin
protect
cat
experiment
challeng
depend
upon
strain
particularli
dose
challeng
viru
low
dose
exposur
tcidso
result
protect
vaccin
cat
higher
dose
exposur
tcidso
result
virtual
protect
even
induc
acceler
fip
mani
case
date
acceler
fip
report
field
condit
howev
field
studi
conduct
manufactur
multicat
facil
also
fail
demonstr
signific
differ
incid
fip
kitten
mortal
vaccin
unvaccin
cat
fanton
summari
coronavirus
seen
repres
larger
rna
viru
superfamili
whose
virus
employ
uniqu
interest
replic
scheme
addit
tradit
antigenicallydefin
boundari
within
coronavirida
fall
emerg
relationship
prcv
tgev
fipv
fecv
provid
fruit
area
viral
pathogenesi
research
knowledg
molecular
biolog
felin
coronavirus
limit
compar
mhv
ibv
clone
character
fipv
n
orf
provid
use
inform
recent
character
mhv
receptor
provid
impetu
identif
fipv
receptor
develop
ts
vaccin
also
repres
signific
achiev
vaccin
provid
encourag
control
fipv
infect
still
question
concern
safeti
experiment
condit
efficaci
field
condit
regard
immunopathogenesi
fip
becom
even
complex
recent
advanc
understand
ade
fipv
infect
identif
discret
epitop
mediat
ade
may
allow
develop
recombinantengin
fipv
vaccin
enhanc
epitop
delet
addit
work
vennema
colleagu
recombin
vaccinia
viru
express
protein
fipv
deserv
consider
regard
treatment
fip
weiss
colleagu
work
specif
antivir
drug
hope
expand
perhap
evalu
combin
ribavirin
interferon
vivo
addit
addl
jarrett
data
regard
control
enzoot
fip
catteri
encourag
howev
lack
diagnost
test
specif
fipv
exposur
remain
signific
hurdl
routin
control
fipv
infect
